News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aileron Therapeutics To Present At 2014 Leerink Swann and Company Global Healthcare Conference


2/10/2014 9:39:45 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aileron Therapeutics, Inc. a clinical stage biopharmaceutical company that is developing first-in-class therapeutics based on its proprietary Stapled Peptide drug platform, today announced that Joseph Yanchik III, Chief Executive Officer of Aileron Therapeutics, will present at the Leerink Global Healthcare Conference on Wednesday, February 12th at 11:30a.m. EST at the Waldorf Astoria Hotel in New York.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES